Clinical Neuroscience Solutions, Inc

Home , Clinical neuroscience, Epix Pharmaceuticals

JOHN MARK JOYCE, M.D. CNS HEALTHCARE OF JACKSONVILLE

Affiliation Investigator Clinical Neuroscience Solutions, Inc. 5200 Belfort Road, Suite 420, Jacksonville, FL 32256 2003 - Present

Clinical Trial Experience 2003-Present Principal Investigator on over 200 phase II – IV clinical and Interest trials in children, adults, and geriatrics.

Sleep Disorders, Chronic Pain, Osteoarthritis, Smoking Cessation, Alcohol Dependence, Substance Use Disorders, Migraine, Alzheimer’s Disease, Rheumatologic Disorders, Skin Disorders, Women’s Health, Attention Deficit Hyperactivity Disorder, Autism, Mood Disorders, Obesity, Binge Eating Disorder, Bipolar Disorder, Dementia, Diabetes, Diabetic Peripheral Neuropathy, Diverticulitis, Fatigue, Female Sexual Arousal Disorder, Gambling, Anxiety Disorders, Gout, Hot Flashes, Hypertension, Irritable Bowel Syndrome, Mild Cognitive Impairment, Obsessive-Compulsive Disorder, Fibromyalgia, Oppositional Defiant Disorder, Panic Disorder, Post Traumatic Stress Disorder, Schizophrenia, Sexual Dysfunction, Social Phobia, Stuttering, Vulvar & Vaginal Atrophy, Chronic Idiopathic Constipation, Opioid Induced Constipation, Asthma, COPD, Flu Treatment, Down Syndrome, Post Herpetic Neuralgia and Hyperlipidemia

Professional Training and 1988 -1989 Internal Medicine and Neurology Internship, Emory Experience University School of Medicine, Atlanta GA

1989 - 1992 Psychiatry Residency, Emory University School of Medicine, Atlanta, GA

1991-1992 Chief Resident, Department of Psychiatry, Grady Memorial Hospital, Atlanta, GA

1992-2000 Private Practice, Atlanta, GA

1992 – 1996 Consultant, Gwinnett/Rockdale/Newton Recover Center

1996 – 2000 Medical Director, Gwinnett/Rockdale/Newton Recovery Center

2001-2006 Director of Psychiatric Services, Duval County Pretrial Detention Center

2001- Present Private Practice, Jacksonville, FL

CNS Healthcare Jacksonville - 5200 Belfort Road, Suite 420, Jacksonville, Florida 32256 Tel: (904) 281-5757 Fax: (904) 281-5758 Mobile (904) 654-6451 www.cnshealthcare.com/Jacksonville [email protected]

Page 1 of 3 CNS Healthcare of Jacksonville Clinical Neuroscience Solutions, Inc.

JOHN MARK JOYCE, M.D. CNS HEALTHCARE OF JACKSONVILLE

Education 1980-1984 B.S., Birmingham Southern College Department of Psychology Birmingham, AL

1984-1988 M.D., University of Alabama School of Medicine Birmingham, AL

License/ Accreditation Florida: No. ME 81135 Georgia: No. 032593 Drug Enforcement Administration: BJ7100833 (Florida) & BJ3162601 (Georgia) American Board of Psychiatry and Neurology

Industry Contacts Industry contracts include: Abbott, Addrenex Pharma, Alder, Alkermes, Allergan, Allon Therapeutics, Arena, Array, AstraZeneca, Avanir, Avera, Bristol-Myers Squibb, Boehringer Ingelheim, Cephalon, Daiichi Sanko, DOV, Eli Lilly, Epix Pharmaceuticals, Euthymics, Forest, Furiex, GlaxoSmithKline, Indevus, Johnson & Johnson, Labopharm, Labrys, Lundbeck, Merck, McNeil, Myriad, Neurocrine, New River Pharmaceuticals, Novartis, NovoNordisk, Ono Pharma USA, Organon, Otsuka, Pfizer, Purdue, Rexhan, Sanofi, Sepracor, Shionogi, Shire, Solvay, Somaxon, Sunovion, Supernus, Synergy, Takeda, Targacept, TransTech, Vanda and Wyeth, AssureRx, Astellas, Dr. Reddy’s, Edgemont,IronShore, Nestle Health Science, Palatin, Noven, Regeneron, Tal Medical, Genomind, Medgenics, Roche, Axsome, Neuralstem, Colucid, Alcobra, Acadia, NLS Pharma.

Original Articles McCallum, D.M., McCallum, R., Gurwitch, R.H., & Joyce, J.M. (1986). Assessing Perceptions of Dental Health Behaviors. Clinical Preventative Dentistry, 8, 27-30.

Hughes, T.A., Moore, M.A, Joyce, J.M., Go, R.C.P, Segrest, J.P. & Blackwell, T. (1992). Sexual Differences in Lipoprotein Composition in Dyslipidemic Hypertension with Premature Atherosclerosis: Deficiency of HDL-l and HDL-M “A-I Alone” Particle. Journal of Laboratory and Clinical Medicine, 119(1).

Weisler, R., Joyce, J.M, McGill, L., Lazarus, A., Szamosi, J., Eriksson, H. (2009). Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo- Controlled Study. CNS Spectr. 2009; 14(6):299-313.

El-Khalili N., Joyce M., Atkinson S., Buynak R. J., Datto C., Lindgren P.,

Page 2 of 3 CNS Healthcare of Jacksonville Clinical Neuroscience Solutions, Inc.

JOHN MARK JOYCE, M.D. CNS HEALTHCARE OF JACKSONVILLE

Eriksson H., Extended –Release Quetiapine Fumarate (Quetiapine XR) as Adjunctive Therapy in Major Depressive Disorder (MDD) in Patients with an Inadequate Response to Ongoing Antidepressant Treatment: A Multicentre, Randomized, Double-Blind, Placebo Controlled Study. International Journal of Neuropsychopharmacology, Vol 23:1-16, February 2010.

Abstracts Joyce, M., Khan, A., Atkinson, S., Eggens, I., Baldytcheva, I., Brecher, M., (2007). Efficacy and Safety of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Generalized Anxiety Disorder (GAD). American Psychiatric Association Convention.

Khan, A., Joyce, M., Atkinson, S., Eggens, I., Baldytcheva, I., Brecher, M. (2007). Efficacy and Safety of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Generalized Anxiety Disorder (GAD). Anxiety Disorders Association of America, 28th Annual Conference.

El-Khalili, N., Joyce, M., Atkinson, S., Buynak, R., Datto, C., Lindgren, P., Eriksson, H., Brecher, M., (2007). Adjunctive Extended Release Quetiapine Fumarate (Quetiapine XR) in Patients with Major Depressive Disorder and Inadequate Antidepressant Response. American Psychiatric Association Convention.

Weisler, R., Joyce, M., McGill, L., Lazarus, A., Schollin, M., Brecher, M., (2007). Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy for Major Depressive Disorder (MDD): A Double-Blind Placebo Controlled Study.

Hughes, T.A., Moore, M.A., Joyce, J.M., Go, R.C.P, Segrest, J.P., & Blackwell, T. (1998). Family with Hypertiglyceridemia and Premature Atherosclerosis: “Light ApoA-1” Deficiency. Atherosclerosis, 8, 578a.

Page 3 of 3 CNS Healthcare of Jacksonville Clinical Neuroscience Solutions, Inc.